Clinical Strategy @Teladoc | Endocrinologist via @UCSF | Interests in diabetes, obesity | population health & prevention | behavior change | tweets my own

Salt Lake City, UT
Joined June 2017
🚨 BREAKING: Zepbound (#Tirzepatide) becomes the first-ever FDA-approved drug for Obstructive Sleep Apnea (OSA)! 🌟 fda.gov/news-events/press-an…
15
232
22
860
111,851
If MAHA cares about “making Americans healthy” I expect to see: Expansion of Medicare & Medicaid Vaccine requirements for schools Affordable healthcare for ALL Implementing modern agriculture tools for food crops Addressing lies about conventionally-grown foods 1/
109
91
20
644
52,459
Tejaswi Kompala retweeted
Just asked @ZekeEmanuel about what we should be doing next for America’s health to have the greatest impact. His answer made me jump out of my chair. Invest in our children. The earlier, the better. Their nutrition, their education, the right early inventions. We can afford it *and* it pays for itself. More to come on the Second Opinion pod!
17
19
4
105
14,985
Tejaswi Kompala retweeted
Today is the last day for us to #DoSomething to get @KamalaHarris elected! What a remarkable few months this has been — in record time, she’s built an extraordinary campaign, set forth a clear policy agenda, and proven again and again that she will be working not for herself, but for you. She’s done it all with intelligence, integrity, and grace. She has gone above and beyond. She’s more than done her part.
4,767
3,825
283
25,328
1,400,797
After a strong start, competition for @novonordisk @EliLillyandCo is coming in the #weightloss space, with widespread innovation to bring options for more people @amgen @Roche @AltimmuneInc @StructureTx @Viking_VKTX @pfizer @Boehringer economist.com/business/2024/… @TheEconomist
10
100
14
298
57,060
The benefits of incretin-memetic drugs (IMD) are clear 💉 The benefits of physical activity and nutrition therapy are clear 🏋️‍♂️🥦 This is not an either/or debate. A comprehensive weight management program should include both. Figure Source: doi.org/10.1111/obr.13841
3
9
1
25
2,594
*Breaking* Top-line results positive of the highly anticipated #SOUL trial, the first powered CVOT of an oral #GLP1RA 14% reduction in MACE with oral semaglutide among 9,650 people with T2D and established CV disease and/or CKD novonordisk.com/content/nnco…
2
65
6
131
39,631
Interested in personalized nutrition? Our new pub examining whether weight loss differs between genotype-concordant and genotype-discordant diets was published in @NatureComms and is featured as an Editors’ Highlight. A thread on findings below. Link: shorturl.at/JL238
17
94
30
377
213,044
Retatrutide, the triple G, Glucagon-GIP-GLP-1 based triagonist produces substantial resolution of liver fat #NAFLD in PPL with #obesity #ADA2023 @ADA_DiabetesPro @AmDiabetesAssn #NASH trial coming
8
103
22
364
87,256
This is preliminary data that needs to undergo peer review (presented as an abstract at ENDO) but incredibly relevant given AMA's new policy clarifying role of BMI as a measure in medicine. This data using DEXA suggests we are UNDERESTIMATING obesity, particularly among women and people who identify as Hispanic or Asian. Using standard obesity cutoffs for both BMI and total body fat, this study found DEXA rated 74% of participants as having obesity based on body fat compared with 36% based on BMI. Among the 64% of the study group who did not have obesity according to BMI, DEXA scans showed 53% of this subgroup did have obesity based on body fat percentages. Among those with a normal BMI, 43% had obesity according to DEXA. Further analysis showed that adding waist circumference to BMI to enlarge the diagnostic net for obesity, it cut the percentage of adults missed as having obesity by BMI alone nearly in half. Additional analyses showed that the rate of missed diagnoses of obesity by BMI was only most common among people of Hispanic or Asian ethnicity, with both groups showing a 49% rate of obesity by DEXA among those with normal-range BMIs. Link to article: medscape.com/viewarticle/993…
17
17
6
65
27,029
Eli Lilly announced today that it will cut the list prices for its most commonly prescribed insulins, including Humalog and Humulin, by 70%! The drug maker will also expand a program that caps insulin costs for patients at $35 per month. Full scoop - l8r.it/72SB
3
1
14
1,459
As we rapidly accelerate toward this future of obesity, I would remind everyone that unless systemic changes are made which require changing fundamental structures of our society, this will be inevitable. Once people develop obesity, we have no evidence that the neurohormonal and immunologic changes are reversible, even with weight reduction. It’s why urgency regarding prevention is critical. I’m not going to lie; I don’t sense any urgency at the top level—no talk of obesity by major stakeholders.
27
41
14
202
106,665
Big News! House Appropriations Committee asks for Medicare Part D coverage of anti-obesity meds. If true, this would change the entire med coverage landscape as CMS often sets the bar for commercial payors. H/t @ConscienHealth pink.pharmaintelligence.info…
4
11
1
33
Do you read package inserts? I ❤️them. Here are some useful tidbits from Mounjaro's PI (vs. semaglutide) that you should know before you rx your first one: 1/ #obesity #weight #weightloss #diabetes #endocrinology #pharmacology #pharmacy
1
7
1
28
Reproductive health decisions should be made between a patient and their doctor. Full stop.
3,766
3,233
629
19,269